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uncertainty. Our data recommend daily kV CBCT imaging and 
setup corrections for this group of patients.  
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Purpose or Objective: To review CBCT images of 35 pts 
receiving radical irradiation for localized prostate cancer, 
according to an IGRT protocol based on the use of 
intraprostatic calcifications as natural fiducial markers for 
the evaluation of inter-fraction organ motion. 
 
Material and Methods: Between 2013 and 2014, 646 KVCBCT 
images of 35 pts radically irradiated with moderately 
hyopofractionated VMAT (2.5 Gy/fract.- 70 Gy in 28 fract.) 
for localized prostate cancer were acquired according to an 
IGRT protocol aimed at evaluating the role of intraprostatic 
calcifications as natural fiducial markers. All the evaluated 
pts presented at least 3 calcifications of >2 mm located 
inside or at the borders of the CTV and contoured on high 
resolution CT-simulation scans and on each CBCT (mean: 18 
CBCT/patient). In order to assess the internal stability of the 
calcifications the distances between them were measured for 
each patient on both CT-simulation scans and each CBCT, 
then mean ± SD of differences between distances was 
calculated. Distances between calcifications and the center 
of mass of CTV were also calculated in 21 patients by drawing 
CTV on 360 CBCT images, contoured by a same physician. The 
center of CTV mass spatial coordinates (X, Y, Z) was 
determined for each CTV and finally the distances between 
the center of the CTV and the center of each calcification 
were measured. Stability of calcifications in respect of CTV 
was assessed by calculating mean values ± SD of measured 
distances. 
 
Results: The mean value of differences in distances between 
calcifications was -0.04 mm ± 1.54 SD, with 95% of values 
contained inside 3 mm (μ ± 2SD). The mean value of 
differences in distances between calcifications and center of 
mass of CTV (Fig. 1) was -0.03 mm ± 1.55 SD, with 95% of 
values contained inside 3 mm (μ ± 2SD). 
 
 
 
Conclusion: Our results derived from the analysis of a large 
data set of CBCT images confirm that intraprostatic 
calcifications, when >2 mm and present at least Nr.=3, 
properly selected and contoured, can be used as very reliable 
natural fiducials, with potential reduction of iatrogenic risks 
and costs associated with the implantation of fiducial 
markers for prostate cancer IGRT.  
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Purpose or Objective: Bony anatomy is used to match anal 
cancer patients treated using volumetric modulated arc 
therapy (VMAT). Only extreme volume changes due to 
bladder, rectum or bowel filling are currently highlighted to 
the responsible clinician. This study aims to determine the 
impact that changes in bladder volume has on the dose to the 
small bowel over the course of the treatment by comparing 
the dose to volumes outlined on cone-beam CT (CBCT) to the 
initial planned dose statistics. A more representative value of 
accrued dose to the small bowel over the course of treatment 
can also be gained. 
 
Material and Methods: Ten patients who were treated with 
VMAT for anal cancer were selected for this study. Weekly 
cone beam CT images were acquired to monitor extreme 
changes in bladder and rectum filling. Patients were asked at 
both planning CT and treatment to have a comfortably full 
bladder. The bladder and small bowel (contained within the 
scan) were outlined on three CBCTs by one clinician; week 
one, mid treatment and final week. The bladder volumes 
were compared over the course of the treatment and the 
maximum small bowel dose, amount of small bowel receiving 
30Gy (V30Gy) and 40Gy (V40Gy) were recorded. 
 
Results: The results in Table 1 show the variation in bladder 
volume. The V40Gy bowel volume was plotted against the 
difference between the bladder volume at CBCT and the 
initial planning scan with the intercept for the linear trends 
set to the planning CT volume for each patient (see Fig. 1). A 
similar trend was found for the V30Gy measurement. There 
was less impact on maximum dose to small bowel with 
changing bladder size.  
 
Table 1 - Bladder Volumes 
Patient 1 2 3 4 5 6 7 8 9 10 
Planning CT 
bladder 
volumes 
[Range 
from 
CBCTs] 
(cm3) 
579 
[426-
618] 
196 
[75-
628] 
278 
[146-
225] 
140 
[57-
248] 
157 
[31-
70] 
170 
[80-
232] 
182 
[146-
215] 
247 
[65-
227] 
239 
[79-
154] 
161 
[81-
191] 
 
 
Conclusion: In eight cases a smaller bladder at CBCT resulted 
in a greater volume of small bowel receiving clinically 
relevant doses compared to the initial planning CT. There 
were two patients where the trend indicated that a larger 
bladder increased small bowel dose. Limitations of this study 
